TOLERABILITY OF ADJUNCTIVE LACOSAMIDE IN PAEDIATRIC PATIENTS AGED 4 TO <16 YEARS WITH FOCAL SEIZURES: AN INTERIM POOLED ANALYSIS OF DATA FROM OPEN-LABEL TRIALS

被引:0
|
作者
Yuen, N. [1 ]
Taeter, C. [2 ]
Beller, C. [1 ]
Daniels, T. [1 ]
Bozorg, A. [1 ]
机构
[1] UCB Pharma, Raleigh, NC USA
[2] UCB Pharma, Braine Lalleud, Belgium
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
p0725
引用
收藏
页码:S132 / S132
页数:1
相关论文
共 50 条
  • [41] ADJUNCTIVE LEVETIRACETAM IN CHILDREN AGED 1 MONTH TO <4 YEARS WITH PARTIAL-ONSET SEIZURES: A LONG-TERM, MULTICENTER, NONCOMPARATIVE, OPEN-LABEL, FOLLOW-UP STUDY
    Pina-Garza, J.
    Schiemann, J.
    Yang, H.
    Duncan, B.
    Hadac, J.
    Hunter, S.
    EPILEPSIA, 2009, 50 : 101 - 102
  • [42] Changes in hormone and lipid levels in male patients with focal seizures when switched from carbamazepine to lacosamide as adjunctive treatment to levetiracetam: A small phase IIIb, prospective, multicenter, open-label trial
    Elger, Christian E.
    Rademacher, Michael
    Brandt, Christian
    Elmoufti, Sami
    Dedeken, Peter
    Eckhardt, Klaus
    Tennigkeit, Frank
    De Backer, Marc
    EPILEPSY & BEHAVIOR, 2016, 62 : 1 - 5
  • [43] Cognitive and Behavioral Effects of Adjunctive Brivaracetam in Children and Adolescents with Focal Seizures: Final Data From an Open-label Follow-up Trial
    Elshoff, Jan-Peer
    Fleyshman, Sofia
    De La Loge, Christine
    Dickson, Najla
    Reichel, Christoph
    Floricel, Florin
    Smeyers, Patricia
    NEUROLOGY, 2023, 100 (17)
  • [44] Efficacy and safety of adjunctive perampanel 4 mg/day in patients aged 4-<12 years with focal-onset seizures or generalised tonic-clonic seizures
    Moretz, Katherine
    Malhotra, Manoj
    Patten, Anna
    Ngo, Leock Y.
    EPILEPSIA, 2021, 62 : 269 - 269
  • [45] Efficacy and Tolerability of Lacosamide in the Concomitant Treatment of 130 Patients Under 16 Years of Age with Refractory EpilepsyA Prospective, Open-Label, Observational, Multicenter Study in Spain
    Carlos Casas-Fernández
    Antonio Martínez-Bermejo
    Miguel Rufo-Campos
    Patricia Smeyers-Durá
    José L. Herranz-Fernández
    Salvador Ibáñez-Micó
    Jaume Campistol-Plana
    Helena Alarcón-Martínez
    Jaime Campos-Castelló
    Drugs in R&D, 2012, 12 (4) : 187 - 197
  • [46] Efficacy and Tolerability of Lacosamide in the Concomitant Treatment of 130 Patients Under 16 Years of Age with Refractory Epilepsy A Prospective, Open-Label, Observational, Multicenter Study in Spain
    Casas-Fernandez, Carlos
    Martinez-Bermejo, Antonio
    Rufo-Campos, Miguel
    Smeyers-Dura, Patricia
    Herranz-Fernandez, Jose L.
    Ibanez-Mico, Salvador
    Campistol-Plana, Jaume
    Alarcon-Martinez, Helena
    Campos-Castello, Jaime
    DRUGS IN R&D, 2012, 12 (04) : 187 - 197
  • [47] Safety and Tolerability of Adjunctive Eslicarbazepine Acetate (ESL) in Pediatric Patients (Aged 4-17 Years) with Partial-Onset (Focal) Seizures (POS)
    Mintz, Mark
    Pina-Garza, Jesus
    Wolf, Steven
    McGoldrick, Patricia
    Grinnell, Todd
    Cantu, David
    Costa, Raquel
    Moreira, Joana
    Li, Yan
    Jozwiak, Sergiusz
    Blum, David
    NEUROLOGY, 2018, 90
  • [48] Long-Term Quality of Life in Patients With Focal Seizures Treated With ESL: Pooled Analysis From 3 Phase III Open-Label Extension Studies
    Cantu, David
    Krishnaiengar, Suparna
    Thomases, Daniel
    Mehta, Darshan
    Hall, Diane
    Zhang, Yi
    Gama, Helena
    Pereira, Ana
    Grinnell, Todd
    NEUROLOGY, 2023, 100 (17)
  • [49] Analysis of Hematological and Serum Chemistry Abnormalities in Clinical Trials of Adjunctive Eslicarbazepine Acetate in Children (Aged 4-17 Years) with Focal Seizures
    Kotagal, Prakash
    Loddenkemper, Tobias
    Grinnell, Todd
    Cantu, David
    Li, Yan
    Costa, Raquel
    Moreira, Joana
    Blum, David
    NEUROLOGY, 2019, 92 (15)
  • [50] Analysis of Psychiatric Adverse Events and Suicidality in Clinical Trials of Adjunctive Eslicarbazepine Acetate in Children (Aged 4-17 Years) with focal Seizures
    Salpekar, Jay
    Mintz, Mark
    Mintz, Pnina
    Grinnell, Todd
    Cantu, David
    Li, Yan
    Vieira, Mariana
    Pereira, Ana
    Blum, David
    NEUROLOGY, 2019, 92 (15)